Interleukin 3: biological and clinical effects.
Oster
W
W
Behringwerke AG, Marburg, Federal Republic of Germany.
Schulz
G
G
D000818:Animals; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D006402:Hematologic Diseases / Q000188:drug therapy; D006801:Humans; D007377:Interleukin-3 / Q000378:metabolism / Q000494:pharmacology* / Q000502:physiology* / Q000627:therapeutic use; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy; D016185:Receptors, Interleukin-3 / Q000378:metabolism
D007377:Interleukin-3; D016185:Receptors, Interleukin-3; D016178:Granulocyte-Macrophage Colony-Stimulating Factor